Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, Belgium, Russia, UK, Taiwan, and China sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research.


AI/ML

Health & Wellness

Pharmaceutical

Insilico Medicine

Alex Zhavoronkov

Peng Dai (Simon)

Mengru Zhang

June Tan

Tatsiana Limarenka

Liu Yichen

Daniil Polykovskiy

Bei Zhang

亦谦 谢

Petrina Kamya

海彬 王

Dmitry Sadovnikov

Roman Kudrin

Igor Gavrilov

Quentin V.

Frank Pun

Andy Min Xie

Sujata Rao

Jimmy Yen-Chu Lin

Feng Ren

Michelle Chen

Kan Chen

Min Fang

Alex Aliper

The leadership team at Insilico Medicine has a history of experience in research, finance, and biochemistry. Many members of the team have their PhDs in relevant fields, and have worked for companies such as WuXi Biologics, BioMarin Pharmaceutical Inc., and Merck & Co. In addition, the team has experience working in academic settings such as the Moscow Institute of Physics and Technology, Harvard University, and ETH Zurich.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Insilico Medicine

Board of Directors

CEO and Executive Team